NICE Final Guidance Backs Fezolinetant When HRT Is Unsuitable
NICE now recommends fezolinetant for moderate to severe menopause-related hot flushes and night sweats when HRT is unsuitable, with required liver monitoring.
Showing 193-204 of 206 articles
NICE now recommends fezolinetant for moderate to severe menopause-related hot flushes and night sweats when HRT is unsuitable, with required liver monitoring.
Epic and Oracle are expanding AI-assisted health workflows, but the evidence and oversight required depend on what each software function actually does.
Police and prosecutors say expert witness Peter Hindmarsh did not reveal a hospital investigation before his first evidence in the Lucy Letby trial.
Younger stroke patients face deep cognitive and mental health declines, with work loss and weak rehabilitation support worsening outcomes.
A 69-pair cohort linked maternal activity with some brain and executive-function measures at age 8, but it could not establish a causal benefit.
A FAERS analysis found a stronger NAION reporting signal for Wegovy than Ozempic, but it could not measure incidence or prove causation.
Retsef Levi's role in reviewing Covid vaccine safety drew scrutiny over his research record, while HHS defended his qualifications for ACIP.
Emergency visits for children's non-traumatic dental problems rose sharply through 2022, exposing gaps in prevention and access to dentists.
Robert Kennedy Junior is overhauling federal vaccine advisory panels, raising concern over evidence standards and public trust.
Public health alarm is growing over federal medical policy shifts involving fluoride, vaccine advice and agency leadership.
Donna Ockenden will chair the independent Leeds maternity review, with case reviews expected to cover harm from 2011 through 2025.
A pediatric dental crisis is sending more children to emergency rooms as access gaps and fluoride fights deepen preventable pain.